There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for BioLife Solutions Inc. (BLFS) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.76, or 4.16%, to $19.01. The BioLife Solutions Inc. has recorded 402 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that BioLife Solutions Reports First Quarter 2023 Financial Results.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
This NASDAQ-listed company operates within the Medical Instruments & Supplies industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $18.25 and fluctuated between $19.54 as its day high and $16.28 as its day low. The current market capitalization of BioLife Solutions Inc. is $729.82M. A total of 0.89 million shares were traded on the day, compared to an average of 278.54K shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, BLFS has seen 3 BUY and 23 SELL insider trades, representing the acquisition of 20,938 and the disposition of 53,229 shares. Over the last 12 months, there were 76 BUYs and 117 SELLs from insiders. Insiders purchased 404,239 shares during that period but sold 254,766.
In the most recent transaction, Mathew Aby J. sold 10,000 shares of BLFS for 19.25 per share on Apr 20. After the transaction, the EVP & Chief Scientific Officer now owns 268,352 company shares. In a previous transaction on Apr 19, Mathew Aby J. sold 10,000 shares at 19.47 per share. BLFS shares that EVP & Chief Scientific Officer owns now total 268,352.
Among the insiders who sold shares, Schulz Marcus disposed of 430 shares on Apr 19 at a per-share price of $19.33. This resulted in the Chief Revenue Officer holding 41,062 shares of BLFS after the transaction. In another insider transaction, Aebersold Sarah sold 292 shares at $19.33 per share on Apr 19. Company shares held by the Chief Human Resources Officer now total 42,059.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for BLFS in the last 3 months, the mean price target is $30.71 with high estimates of $34.00 and low estimates of $27.00. In terms of 52-week highs and lows, BLFS has a high of $26.96 and a low of $10.40.
As of this writing, BLFS has an earnings estimate of -$0.18 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.13 per share and a lower estimate of -$0.24. The company reported an EPS of -$1.15 in the last quarter, which was -576.50% lower than expectations of -$0.17.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. BLFS’s latest balance sheet shows that the firm has $69.87M in Cash & Short Term Investments as of fiscal 2021. There were $26.88M in debt and $39.97M in liabilities at the time. Its Book Value Per Share was $8.51, while its Total Shareholder’s Equity was $480.75M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BLFS is Buy with a score of 5.00.